Precision Biologics to Deliver two Oral Presentations on our Clinical and Scientific Programs at 6th Annual Neoantigen Based Therapies Summit, October 26-28th, Digital Event

Dr Massimo Fantini, Director of Research is Presenting the following Talk entitled : “Stability Tests to Monitor the Shelf Life Of Monoclonal Antibodies Employed in Cancer Immunotherapy”, on October 26,2021

Dr. Philip M Arlen, MD, President and CEO is Presenting the Following Talk entitled: “Developing mab Therapies From Tumor Neoantigens”, on October 28,2021